Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch

[1]  H. Miyake,et al.  Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection. , 2012, Urologic oncology.

[2]  S. Shariat,et al.  Impact of gender on bladder cancer incidence, staging, and prognosis , 2011, World Journal of Urology.

[3]  A. Papatsoris,et al.  Expression of ERβ and Its Co-Regulators p300 and NCoR in Human Transitional Cell Bladder Cancer , 2011, Urologia Internationalis.

[4]  M. Pike,et al.  Lower Risk in Parous Women Suggests That Hormonal Factors Are Important in Bladder Cancer Etiology , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[5]  G. Scambia,et al.  Changes in the expression of oestrogen receptors and E‐cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma , 2011, Histopathology.

[6]  M. Melachrinou,et al.  Inverse expression of estrogen receptor‐β and nuclear factor‐κB in urinary bladder carcinogenesis , 2010, International journal of urology : official journal of the Japanese Urological Association.

[7]  R. Bryan,et al.  Cadherin switching and bladder cancer. , 2010, The Journal of urology.

[8]  I. Leav,et al.  ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. , 2010, Cancer cell.

[9]  E. Neilson,et al.  Biomarkers for epithelial-mesenchymal transitions. , 2009, The Journal of clinical investigation.

[10]  D. Jarrard,et al.  Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation. , 2008, Endocrine-related cancer.

[11]  M. Loda,et al.  Identification and Prognostic Significance of an Epithelial-Mesenchymal Transition Expression Profile in Human Bladder Tumors , 2007, Clinical Cancer Research.

[12]  H. Wallerand,et al.  N-Cadherin as a Novel Prognostic Marker of Progression in Superficial Urothelial Tumors , 2006, Clinical Cancer Research.

[13]  D. Michaud,et al.  Hormonal and reproductive factors and the risk of bladder cancer in women. , 2006, American journal of epidemiology.

[14]  G. Sonpavde,et al.  Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. , 2006, Cancer.

[15]  T. Wheeler,et al.  E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder. , 2001, Urology.

[16]  K. Knudsen,et al.  Expression of E-, P-, n-cadherins and catenins in human bladder carcinoma cell lines. , 2000, The Journal of urology.

[17]  T. H. van der Kwast,et al.  E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ. , 2000, Cancer research.

[18]  F. Mostofi,et al.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. , 1998, The American journal of surgical pathology.